Kirk Allen Coleman - Mar 22, 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
Chief Financial Officer
Signature
/s/ Kirk Allen Coleman
Stock symbol
TFFP
Transactions as of
Mar 22, 2023
Transactions value $
$0
Form type
4
Date filed
3/24/2023, 06:03 PM
Previous filing
Mar 13, 2023
Next filing
Aug 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +100K $0.00 100K Mar 22, 2023 Common Stock 100K $0.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under TFF Pharmaceuticals, Inc. 2021 Stock Incentive Plan. The Options shall vest and first become exercisable as follows: one-quarter of the Options shall vest and first become exercisable on March 22, 2024 and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on June 22, 2024.